SCHEMBL3845295

SCHEMBL3845295

Clc1cc(-c2cnn(C(c3ccccc3)(c3ccccc3)C3C=CC=CC3)c2)cn2c(-c3nccs3)cnc12

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.35
MET P08581 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3844955 0.83 MET (0.32) MET
SCHEMBL3846073 0.83 KDR (0.31) KDR
SCHEMBL3845293 0.82 KDR (0.42) KDRMET
SCHEMBL3849217 0.79
SCHEMBL3847950 0.76 KDR (0.32) KDR
SCHEMBL3847157 0.75 KDR (0.31) KDR
SCHEMBL3847826 0.73
SCHEMBL3852057 0.71 KDR (0.35) KDR
SCHEMBL3847280 0.70 AKT1 (0.31)
SCHEMBL3852713 0.69 FLT3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed